New Zealand's Air Quality Improving, But Winter Smoke Still An Issue
'Air quality in New Zealand has improved over time thanks to a combination of local and national action, but winter remains a challenge in many towns,' said Dr Chris Daughney, Chief Science Advisor for the collective of regional and unitary councils - Te Uru Kahika.
'When smoke from wood burners and coal fires builds up in calm, cold conditions, it can affect the health of whole communities.
'The good news is that monitored sites in most towns are now meeting national air quality standards for particulate matter (PM10) and continue to show improvements since monitoring began.
'However, most monitored places exceed international guidelines for fine particulate matter (PM2.5) which comes from combustion sources and poses significant health risks,' said Dr Daughney.
The LAWA Air Quality National Picture 2025 provides analyses of monitoring site data from regional and unitary councils across the country.
Although PM2.5is not yet regulated under New Zealand's National Environmental Standards for Air Quality (NES-AQ), the National Picture outlines that 13 regions are now actively monitoring this harmful pollutant, and the number of monitored sites has increased in recent years.
In 2024, only three monitoring sites in New Zealand met both the daily and annual WHO guidelines for PM2.5. These were at Whareroa Marae in Mount Maunganui, Whangārei, and central Wellington. The 2021 WHO guidelines are stricter than previous guidelines and reflect growing understanding of the health impacts from long-term exposure to fine particles.
Dr Daughney said the results presented on the LAWA website reinforce the value of council monitoring networks.
'Although it is not yet regulated under a national standard, many regional and unitary councils are already monitoring the smaller PM2.5 particles to better understand local air quality and to prepare for future regulation. However, without a New Zealand-specific standard in place, it's a challenge for councils to justify further investment in monitoring equipment and analysis.
'The science is clear that reducing fine particulate matter pollution improves public health, especially for children, older adults, and those with respiratory conditions,' said Dr Daughney.
While winter conditions continue to present challenges, the LAWA Air Quality National Picture also highlights definite progress. There are improving air quality trends for 30 of the 44 long-term PM10 monitoring sites over the last 10 years and only 4 sites have seen a decline.
LAWA Air Quality Science Lead Teresa Aberkane explains that air quality is fascinating because it responds to human behaviour.
'Many places like Timaru, Tokoroa, and Kaiapoi have taken active steps to reduce winter emissions, and we're seeing those actions reflected in the data.
'That's the value of ongoing monitoring, when we measure and report, we can take steps to make a difference to the air we breathe,' said Ms Aberkane.
Many of these improvements are the result of sustained investment by councils in cleaner heating technology, community education, and local bylaws aimed at phasing out high emission burning. Transport choices also have a big impact on air quality and walking, cycling, and public transport are cleaner options than private vehicle use.
LAWA Chair Dr Tim Davie said everyone can play a role in cleaner winter air.
'The data shows we've made good progress. Now it's about staying on track and continuing to act where it matters most.
'With winter here, we're encouraging people to check their local air quality and take steps to minimise smoke. Avoiding lighting fires on still weather nights is best, but if people are going to use their log burner, then using dry, untreated wood with a clean burning technique can help reduce the amount of pollution into the local neighbourhood.
'We're pleased to make real-time air quality information available to New Zealanders for free on the LAWA website, alongside useful evidence-backed factsheets,' said Dr Davie.
Air quality information for 150 monitoring sites is available at www.lawa.org.nz/explore-data/air-quality, along with practical tips on what households can do to help.
Further information
PM2.5 and PM10 are forms of air pollution measured in micrometres. PM2.5 poses greater health risks due to its ability to enter the lungs and bloodstream.
The World Health Organization's 2021 air quality guidelines are based on updated scientific evidence of health impacts from fine particulate matter.
The Ministry for the Environment has announced that the National Environmental Standards for Air Quality (NES-AQ) will be reviewed and updated by 2026 to include PM2.5
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
9 hours ago
- NZ Herald
Alcohol industry pressures NZ officials on taxes, FASD strategy
'They certainly haven't had any particular special treatment or back door into the ministry. It's been a deliberate, structured approach. They've had quarterly meetings with the team,' Old said. 'I can absolutely and categorically say that there is no veto power. So if the industry says 'we don't want to see this', that has no bearing on the outcome. It is a view that is considered alongside a range of other views.' Old accepted that the alcohol industry was motivated by profit. 'I also would hope that, in doing that, they don't want to be doing harm,' he said. 'There's clearly a conflict. But, to my mind, it's not an irreconcilable conflict that would mean that we should just never talk to them.' Alcohol lobbyists were also given a draft investment strategy on how to spend the Alcohol Levy, a ring-fenced fund of $16.6 million for alcohol harm reduction measures. The documents include an email from Spirits NZ to the MOH, saying there was intense interest in the Alcohol Levy, which is funded from a small tax on sales – equivalent to less than one cent on a standard can of beer. 'My members with global links are seeking advice from their HQ's from London to Louisville, Kentucky – yes, this is how important this matter is to them,' the lobbyist says, in a November 2024 email to the MOH. The documents show industry concern the Alcohol Levy would be spent on programmes based on the WHO's SAFER strategy, which says that, globally, a person dies every 10 seconds due to alcohol related causes. 'The WHO SAFER strategies include measures like restricting availability and raising excise taxes,' a submission from the Brewers Association says. 'These broad based initiatives are generally seen as reducing consumption overall and not targeting harmful consumption.' The Brewers Association said there was an 'overemphasis on restrictions' in the WHO guidelines. 'Metrics tied to SAFER principles could incentivise programmes that focus excessively on punitive measures, such as limiting availability and marketing, rather than collaborative, education-based harm reduction approaches.' The Brewers Association also warned against using the Alcohol Levy to fund 'controversial' programmes it believes won't reduce harmful consumption. 'Examples raised in our meeting included research with little application actions in the outcomes, funding of legal support for opposition of licences and replacing sponsorship arrangements in sport organisations with funds from the levy.' The documents, which the MOH tried to withhold using a section of the OIA designed to protect advice between Ministers and officials until overruled by the Ombudsman, also include industry critique of the FASD strategy. Spirits New Zealand, which represents the likes of Asahi, Bacardi, Diageo, Lion, Moet-Hennessy and Pernod Ricard, warned against launching action on FASD without knowing what the prevalence was. It took issue with estimates, based on international studies and expert opinion, that 3-5% of babies – 1800 to 3000 every year – are born with FASD. 'This is simply not credible and is similar to the situation that existed when the last plan was developed in 2016,' the lobbyists say. 'We cannot see how any FASD-prevention plan can be started without good data as a baseline. We would ask that the Public Health Agency give assurances that work on measurement frameworks occurs prior to other plan elements being launched.' Leigh Henderson, chair of the advocacy group FASD-CAN, was concerned the alcohol industry doubted the prevalence of FASD. 'Are they saying, 'Okay, it's all right for 500 babies to be born, but not 1800,'' she asked. 'We know it's not 100 percent preventable, but to try and downplay it in that way is just callous and not recognising the level of the problem.' In a statement chief executive Robert Brewer said Spirits NZ 'categorically denies' downplaying the extent of FASD. 'The Government can't fix a problem if it doesn't know its true extent, level of occurrence, who is affected and why and to do this you need good data. This is basic public policy.' Henderson said the motivation of the industry was clear, given its opposition during the 20-year battle to get mandatory pregnancy warning labels on alcohol. The spirits industry says it supports targeted programmes but believes the draft FASD strategy is too broad. It raised the ad campaign 'Pre-Testie Bestie' as an example, saying its 'ultimate audience seemed to be any woman of child-bearing age who may or may not be having sex and who may or may not be pregnant'. It said that was 'an impossible audience to communicate with' as the campaign, funded by the Health Promotion Agency (HPA), was trying to be both targeted and national. But the HPA (now part of Health New Zealand) said in its 2019 Annual Report that 38% of women aged 18 to 30 saw the campaign and 70% of them got the key message: 'Don't drink if you are or might be pregnant'. The Pre-Testie Bestie ad campaign won five Axis Awards. The spirits industry also took issue with the draft FASD strategy, saying New Zealand is a country where 'alcohol is highly accessible, use is normalised', and there are high rates of hazardous drinking. Brewer said hazardous drinking had declined over the last four years in New Zealand to just 16% of adults. - RNZ
Scoop
2 days ago
- Scoop
Alarm At Singapore's Regressive Vaping Policy: Treating All Vaping As Drug Issue Threatens Evidence-Based Harm Reduction
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) today expressed deep concern over Singapore Prime Minister Lawrence Wong's announcement that the city-state will treat all vaping as a drug issue, implementing jail sentences and severe penalties that risk undermining decades of tobacco harm reduction science. "Singapore's blanket criminalisation of vaping is a backward step that ignores overwhelming global evidence of these products' potential to save lives," declared Nancy Loucas, CAPHRA Executive Coordinator. "Whilst we understand concerns about etomidate-laced products, treating all vaping like dangerous drugs flies in the face of successful harm reduction strategies that have transformed public health outcomes worldwide." PM Wong announced during his National Day Rally speech that Singapore will impose "much stiffer penalties" including jail sentences for vaping offences, stating the government will "treat this as a drug issue" rather than a tobacco control matter. The policy shift comes as etomidate, an anaesthetic agent found in some illegal vapes, is classified as a Class C controlled drug. "Singapore is conflating two entirely different issues – contaminated illegal products and legitimate nicotine vaping devices," said Loucas. "This is like banning all alcohol because some criminals sell methanol-laced spirits. It's a policy failure that will deny adult smokers access to proven harm reduction tools whilst driving the market further underground." Singapore's smoking rates have remained stubbornly stagnant at around 10-16% for over a decade despite implementing comprehensive WHO MPOWER measures. The city-state banned e-cigarettes in 2018, yet continues to struggle with plateauing smoking rates that traditional tobacco control methods have failed to address. "Singapore's own data proves that prohibition doesn't work," charged Loucas. "Smoking rates have flatlined for years despite every possible control measure. Meanwhile, countries embracing regulated harm reduction are seeing dramatic reductions in smoking-related deaths." "The evidence is crystal clear – regulated access to safer nicotine products accelerates smoking decline," said Loucas. "Countries like the UK, Sweden, Japan, and New Zealand are proving that harm reduction saves lives. Singapore is choosing ideology over evidence." "Singapore prides itself on evidence-based policymaking, yet this announcement abandons science for fear-mongering," said Loucas. "Adult smokers deserve access to products that are at least 95% safer than cigarettes, as confirmed by the UK's Royal College of Physicians and countless peer-reviewed studies." CAPHRA acknowledged legitimate concerns about contaminated vaping products but argued that proper regulation, not prohibition, provides the solution. Countries with regulated markets have virtually eliminated dangerous substances whilst providing quality-controlled alternatives. "You don't solve contamination by banning the category – you solve it through proper regulation, quality standards, and legitimate supply chains," explained Loucas. "Singapore's approach will ensure more dangerous products flood the black market whilst denying smokers life-saving alternatives." About CAPHRA CAPHRA Position Statement on Industry Independence: The Coalition of Asia Pacific Tobacco Harm Advocates (CAPHRA) is a regional alliance of consumer tobacco harm reduction advocacy organisations. CAPHRA is not related to, or funded by any commercial interests. It is composed of volunteer consumer advocates from the Asia Pacific Region. We hope putting forward this information would clarify any doubt as to our interests and intentions. CAPHRA stays committed to its mission to educate, advocate and represent the right of adult alternative nicotine consumers to access and use of products that reduce harm from tobacco use. We advocate for the rights of consumers in the Asia-Pacific region to access and use evidence-based, regulated, and properly marketed harm reduction products as a means of reducing the devastating impact of smoking-related diseases.
Scoop
7 days ago
- Scoop
Gaza Health System ‘Catastrophic' With Hospitals Overwhelmed And Medicines Running Out, WHO Warns
12 August 2025 Fewer than half of Gaza's hospitals and under 38 per cent of primary healthcare centres are partially functioning – or are doing so at minimal levels – said Dr. Rik Peeperkorn, World Health Organization (WHO) Representative for the West Bank and Gaza. Bed occupancy in major facilities is exceeding limits by large margins – Shifa Hospital is at 250 per cent capacity, Nasser at 180 per cent, Al-Rantisi at 210 per cent and Al-Ahli at over 300 per cent. Critical supplies running out 'The critical shortage in medications and consumables continue and have only exacerbated, with 52 per cent of the medicines and 68 per cent of consumables at zero stock,' Dr. Peeperkorn told journalists in Geneva, speaking from Jerusalem. 'Hospitals are particularly overwhelmed by injuries from food distribution areas, which are also driving persistent shortages of blood and plasma,' he added, noting that since 27 May, at least 1,655 people have been killed in those areas and more than 11,800 injured. The crisis has been exacerbated by displacement orders in Gaza City that now place WHO's own warehouse in an evacuation zone. Hospitals, primary care centres and ambulance facilities are also located inside or near these areas, threatening further disruption to services. Malnutrition worsening Hunger and malnutrition are worsening rapidly. Since the start of 2025, 148 people have died from malnutrition, including 49 children – 39 of them under five years old. Nearly 12,000 children under five were diagnosed with acute malnutrition in July, the highest monthly figure to date, with more than 2,500 suffering from the most severe form. New threat from meningitis Disease outbreaks are adding to the pressure. Suspected meningitis cases reached 452 between July and early August – the highest number since the escalation began. Guillain-Barré syndrome, a rare post-infection disorder, has also surged, with 76 suspected cases since June. Both conditions are harder to treat due to 'zero stocks' of vital medicines, including intravenous immuneoglobulin and anti-inflammatories, Dr. Peeperkorn said. Access challenges Access for international medical teams and supplies remains a major obstacle. Dr. Peeperkorn said that international medics face entry denials, while key items such as ICU equipment, anaesthesia machines and cold chain supplies continue to be held back. Though WHO managed to bring in 80 trucks of medical supplies since June, he stressed that procedures are slow and unpredictable, with many shipments delayed or denied. 'We need multiple crossings into Gaza opened, procedures simplified, and access impediments lifted,' he said. 'We hear about more humanitarian supplies being allowed in – but it's not happening, or it's happening far too slowly.'
